Table 1.
Analysis of variance for MLN disease severity (MLN-DS) and area under disease progress curve (AUDPC) values using seven segregating F3 populations evaluated for three seasons under MLN inoculated plots.
Trait | Mean (Range) | σ2G | σ2e * | H 2 |
---|---|---|---|---|
CKDHL120918 × CML494 (F3 pop1) | ||||
MLN-DS | 4.52 (3.06–7.12) | 0.41 ** | 0.44 | 0.74 |
AUDPC | 131.9 (92.9–185.8) | 272.20 ** | 230.73 | 0.78 |
CML543 × CML494 (F3 pop2) | ||||
MLN-DS | 5.11 (3.86–6.35) | 0.17 ** | 0.32 | 0.62 |
AUDPC | 140.8 (103.8–168.9) | 141.05 ** | 177.68 | 0.70 |
CKDHL120918 × CML543 (F3 pop3) | ||||
MLN-DS | 4.52 (3.17–6.86) | 0.46 ** | 0.50 | 0.73 |
AUDPC | 126.2 (82.1–201.0) | 282.50 ** | 280.87 | 0.75 |
CKLTI0227 × CKDHL120918 (F3 pop4) | ||||
MLN-DS | 4.60 (2.80–7.65) | 0.69 ** | 0.57 | 0.79 |
AUDPC | 129.1 (92.6–194.7) | 467.78 ** | 299.86 | 0.82 |
CKDHL0089 × CKDHL120918 (F3 pop5) | ||||
MLN-DS | 4.94 (2.85–8.20) | 0.65 ** | 0.72 | 0.73 |
AUDPC | 133.9 (79.9–209.3) | 411.12 ** | 379.39 | 0.76 |
CKDHL0221 × CKDHL120312 (F3 pop6) | ||||
MLN-DS | 4.40 (2.56–6.97) | 0.50 ** | 0.49 | 0.75 |
AUDPC | 125.6 (78.0–187.9) | 374.25 ** | 245.35 | 0.82 |
CKDHL0089 × CML494 (F3 pop7) | ||||
MLN-DS | 4.82 (2.94–7.31) | 0.44 ** | 0.51 | 0.72 |
AUDPC | 134.4 (91.0–191.8) | 300.75 ** | 260.51 | 0.78 |
Across seven populations | ||||
MLN-DS | 4.70 (2.56–8.20) | 0.40 ** | 0.50 | 0.70 |
AUDPC | 132.4 (78.0–209.3) | 265.48 ** | 267.90 | 0.75 |
* and ** indicate significance at P < 0.05 and P < 0.01, respectively MLN-DS = MLN disease severity 42 dpi; AUDPC = area under disease progress curve; σ2G = genotypic variance; σ2e* = error variance confounded with GxE variance; and H2 = broad sense heritability.